{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T06:13:14Z","timestamp":1791267194173,"version":"4.1.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2018-02124"],"award-info":[{"award-number":["2018-02124"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2022-00799"],"award-info":[{"award-number":["2022-00799"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004047","name":"Karolinska Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Leber\u2019s hereditary optic neuropathy (LHON) is driven by mtDNA mutations affecting Complex I presenting as progressive retinal ganglion cell dysfunction usually in the absence of extra-ophthalmic symptoms. There are no long-term neuroprotective agents for LHON. Oral nicotinamide provides a robust neuroprotective effect against mitochondrial and metabolic dysfunction in other retinal injuries. We explored the potential for nicotinamide to protect mitochondria in LHON by modelling the disease in mice through intravitreal injection of the Complex I inhibitor rotenone. Using MitoV mice expressing a mitochondrial-tagged YFP in retinal ganglion cells we assessed mitochondrial morphology through super-resolution imaging and digital reconstruction. Rotenone induced Complex I inhibition resulted in retinal ganglion cell wide mitochondrial loss and fragmentation. This was prevented by oral nicotinamide treatment. Mitochondrial ultrastructure was quantified by transition electron microscopy, demonstrating a loss of cristae density following rotenone injection, which was also prevented by nicotinamide treatment. These results demonstrate that nicotinamide protects mitochondria during Complex I dysfunction. Nicotinamide has the potential to be a useful treatment strategy for LHON to limit retinal ganglion cell degeneration.<\/jats:p>","DOI":"10.1186\/s40478-024-01724-z","type":"journal-article","created":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T16:03:22Z","timestamp":1709309002000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Prophylactic nicotinamide treatment protects from rotenone-induced neurodegeneration by increasing mitochondrial content and volume"],"prefix":"10.1186","volume":"12","author":[{"given":"Amin","family":"Otmani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gauti","family":"J\u00f3hannesson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rune","family":"Brautaset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8301-7358","authenticated-orcid":false,"given":"James R.","family":"Tribble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6194-8397","authenticated-orcid":false,"given":"Pete A.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,1]]},"reference":[{"issue":"4","key":"1724_CR1","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1212\/WNL.0000000000000610","volume":"83","author":"JH Chin","year":"2014","unstructured":"Chin JH, Vora N (2014) The global burden of neurologic diseases. Neurology 83(4):349\u2013351","journal-title":"Neurology"},{"issue":"10","key":"1724_CR2","doi-asserted-by":"publisher","first-page":"e551","DOI":"10.1016\/S2468-2667(20)30190-0","volume":"5","author":"G Deuschl","year":"2020","unstructured":"Deuschl G, Beghi E, Fazekas F, Varga T, Christoforidi KA, Sipido E et al (2020) The burden of neurological diseases in Europe: an analysis for the global burden of disease study 2017. Lancet Public Health 5(10):e551\u2013e567","journal-title":"Lancet Public Health"},{"issue":"11","key":"1724_CR3","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1016\/j.ophtha.2014.05.013","volume":"121","author":"YC Tham","year":"2014","unstructured":"Tham YC, Li X, Wong TY, Quigley HA, Aung T, Cheng CY (2014) Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology 121(11):2081\u20132090","journal-title":"Ophthalmology"},{"key":"1724_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2023.101193","volume":"92","author":"JR Tribble","year":"2023","unstructured":"Tribble JR, Hui F, Quintero H, El Hajji S, Bell K, Di Polo A et al (2023) Neuroprotection in glaucoma: mechanisms beyond intraocular pressure lowering. Mol Aspects Med 92:101193","journal-title":"Mol Aspects Med"},{"issue":"6326","key":"1724_CR5","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1126\/science.aal0092","volume":"355","author":"PA Williams","year":"2017","unstructured":"Williams PA, Harder JM, Foxworth NE, Cochran KE, Philip VM, Porciatti V et al (2017) Vitamin B-3 modulates mitochondrial vulnerability and prevents glaucoma in aged mice. Science 355(6326):756\u2013760","journal-title":"Science"},{"issue":"1","key":"1724_CR6","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.coph.2012.09.008","volume":"13","author":"V Chrysostomou","year":"2013","unstructured":"Chrysostomou V, Rezania F, Trounce IA, Crowston JG (2013) Oxidative stress and mitochondrial dysfunction in glaucoma. Curr Opin Pharmacol 13(1):12\u201315","journal-title":"Curr Opin Pharmacol"},{"issue":"4","key":"1724_CR7","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.optom.2016.09.003","volume":"10","author":"YL Pilz","year":"2017","unstructured":"Pilz YL, Bass SJ, Sherman J (2017) A review of mitochondrial optic neuropathies: from inherited to acquired forms. J Optom 10(4):205\u2013214","journal-title":"J Optom"},{"key":"1724_CR8","doi-asserted-by":"publisher","first-page":"710","DOI":"10.3389\/fneur.2017.00710","volume":"8","author":"C La Morgia","year":"2017","unstructured":"La Morgia C, Di Vito L, Carelli V, Carbonelli M (2017) Patterns of retinal ganglion cell damage in neurodegenerative disorders: parvocellular vs magnocellular degeneration in optical coherence tomography studies. Front Neurol 8:710","journal-title":"Front Neurol"},{"key":"1724_CR9","doi-asserted-by":"publisher","first-page":"33619","DOI":"10.1073\/pnas.2014213117","volume":"117","author":"JM Harder","year":"2020","unstructured":"Harder JM, Guymer C, Wood JPM, Daskalaki E, Chidlow G, Zhang C et al (2020) Disturbed glucose and pyruvate metabolism in glaucoma with neuroprotection by pyruvate or rapamycin. Proc Natl Acad Sci USA 117:33619\u201333716","journal-title":"Proc Natl Acad Sci USA"},{"key":"1724_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2021.101988","volume":"43","author":"JR Tribble","year":"2021","unstructured":"Tribble JR, Otmani A, Sun S, Ellis SA, Cimaglia G, Vohra R et al (2021) Nicotinamide provides neuroprotection in glaucoma by protecting against mitochondrial and metabolic dysfunction. Redox Biol 43:101988","journal-title":"Redox Biol"},{"issue":"7","key":"1724_CR11","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1016\/j.neurobiolaging.2013.01.006","volume":"34","author":"PA Williams","year":"2013","unstructured":"Williams PA, Thirgood RA, Oliphant H, Frizzati A, Littlewood E, Votruba M et al (2013) Retinal ganglion cell dendritic degeneration in a mouse model of Alzheimer\u2019s disease. Neurobiol Aging 34(7):1799\u20131806","journal-title":"Neurobiol Aging"},{"issue":"1","key":"1724_CR12","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1186\/s40478-020-01094-2","volume":"8","author":"RJ Bevan","year":"2020","unstructured":"Bevan RJ, Hughes TR, Williams PA, Good MA, Morgan BP, Morgan JE (2020) Retinal ganglion cell degeneration correlates with hippocampal spine loss in experimental Alzheimer\u2019s disease. Acta Neuropathol Commun 8(1):216","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"1724_CR13","doi-asserted-by":"publisher","first-page":"fcz035","DOI":"10.1093\/braincomms\/fcz035","volume":"1","author":"JR Tribble","year":"2019","unstructured":"Tribble JR, Vasalauskaite A, Redmond T, Young RD, Hassan S, Fautsch MP et al (2019) Midget retinal ganglion cell dendritic and mitochondrial degeneration is an early feature of human glaucoma. Brain Commun 1(1):fcz035","journal-title":"Brain Commun"},{"key":"1724_CR14","doi-asserted-by":"publisher","first-page":"232","DOI":"10.3389\/fnins.2017.00232","volume":"11","author":"PA Williams","year":"2017","unstructured":"Williams PA, Harder JM, Foxworth NE, Cardozo BH, Cochran KE, John SWM (2017) Nicotinamide and WLDS Act together to prevent neurodegeneration in glaucoma. Front Neurosci 11:232","journal-title":"Front Neurosci"},{"issue":"1","key":"1724_CR15","doi-asserted-by":"publisher","DOI":"10.1080\/19420889.2017.1356956","volume":"11","author":"PA Williams","year":"2018","unstructured":"Williams PA, Harder JM, Cardozo BH, Foxworth NE, John SWM (2018) Nicotinamide treatment robustly protects from inherited mouse glaucoma. Commun Integr Biol 11(1):e1356956","journal-title":"Commun Integr Biol"},{"issue":"7","key":"1724_CR16","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1111\/ceo.13818","volume":"48","author":"F Hui","year":"2020","unstructured":"Hui F, Tang J, Williams PA, McGuinness MB, Hadoux X, Casson RJ et al (2020) Improvement in inner retinal function in glaucoma with nicotinamide (vitamin B3) supplementation: a crossover randomized clinical trial. Clin Exp Ophthalmol 48(7):903\u2013914","journal-title":"Clin Exp Ophthalmol"},{"issue":"1","key":"1724_CR17","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1001\/jamaophthalmol.2021.4576","volume":"140","author":"CG De Moraes","year":"2022","unstructured":"De Moraes CG, John SWM, Williams PA, Blumberg DM, Cioffi GA, Liebmann JM (2022) Nicotinamide and pyruvate for neuroenhancement in open-angle glaucoma: a phase 2 randomized clinical trial. JAMA Ophthalmol 140(1):11\u201318","journal-title":"JAMA Ophthalmol"},{"issue":"1","key":"1724_CR18","doi-asserted-by":"publisher","first-page":"210","DOI":"10.3390\/ijms23010210","volume":"23","author":"M Zeviani","year":"2021","unstructured":"Zeviani M, Carelli V (2021) Mitochondrial retinopathies. Int J Mol Sci 23(1):210","journal-title":"Int J Mol Sci"},{"issue":"13","key":"1724_CR19","first-page":"235","volume":"43","author":"X Zhang","year":"2002","unstructured":"Zhang X, Jones D, Gonzalez-Lima F (2002) A potential model for leber\u2019s hereditary optic neuropathy: rotenone effects on retinal ganglion cells. Investig Ophthalmol Visual Sci 43(13):235","journal-title":"Investig Ophthalmol Visual Sci"},{"issue":"8","key":"1724_CR20","doi-asserted-by":"publisher","first-page":"5471","DOI":"10.1007\/s12035-018-1460-7","volume":"56","author":"K Cimdins","year":"2019","unstructured":"Cimdins K, Waugh HS, Chrysostomou V, Lopez Sanchez MIG, Johannsen VA, Cook MJ et al (2019) Amyloid precursor protein mediates neuronal protection from rotenone toxicity. Mol Neurobiol 56(8):5471\u20135482","journal-title":"Mol Neurobiol"},{"issue":"7","key":"1724_CR21","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2012","unstructured":"Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T et al (2012) Fiji: an open-source platform for biological-image analysis. Nat Methods 9(7):676\u2013682","journal-title":"Nat Methods"},{"key":"1724_CR22","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1093\/brain\/awr330","volume":"135","author":"PA Williams","year":"2012","unstructured":"Williams PA, Piechota M, von Ruhland C, Taylor E, Morgan JE, Votruba M (2012) Opa1 is essential for retinal ganglion cell synaptic architecture and connectivity. Brain 135:493\u2013505","journal-title":"Brain"},{"key":"1724_CR23","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jneumeth.2017.01.003","volume":"279","author":"MD Wilson","year":"2017","unstructured":"Wilson MD, Sethi S, Lein PJ, Keil KP (2017) Valid statistical approaches for analyzing sholl data: mixed effects versus simple linear models. J Neurosci Methods 279:33\u201343","journal-title":"J Neurosci Methods"},{"issue":"1","key":"1724_CR24","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1167\/tvst.10.1.22","volume":"10","author":"JR Tribble","year":"2021","unstructured":"Tribble JR, Kokkali E, Otmani A, Plastino F, Lardner E, Vohra R et al (2021) When is a control not a control? Reactive microglia occur throughout the control contralateral pathway of retinal ganglion cell projections in experimental glaucoma. Transl Vis Sci Technol 10(1):22","journal-title":"Transl Vis Sci Technol"},{"issue":"1","key":"1724_CR25","doi-asserted-by":"publisher","first-page":"48","DOI":"10.18637\/jss.v067.i01","volume":"67","author":"D Bates","year":"2015","unstructured":"Bates D, M\u00e4chler M, Bolker B, Walker S (2015) Fitting linear mixed-effects models using lme4. J Stat Softw 67(1):48","journal-title":"J Stat Softw"},{"issue":"1","key":"1724_CR26","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s11940-010-0100-y","volume":"13","author":"AA Sadun","year":"2011","unstructured":"Sadun AA, La Morgia C, Carelli V (2011) Leber\u2019s hereditary optic neuropathy. Curr Treat Options Neurol 13(1):109\u2013117","journal-title":"Curr Treat Options Neurol"},{"key":"1724_CR27","doi-asserted-by":"publisher","first-page":"100881","DOI":"10.1016\/j.preteyeres.2020.100881","volume":"81","author":"RJ Casson","year":"2021","unstructured":"Casson RJ, Chidlow G, Crowston JG, Williams PA, Wood JPM (2021) Retinal energy metabolism in health and glaucoma. Prog Retin Eye Res 81:100881","journal-title":"Prog Retin Eye Res"},{"issue":"1","key":"1724_CR28","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s40478-023-01513-0","volume":"11","author":"JR Tribble","year":"2023","unstructured":"Tribble JR, Hagstr\u00f6m A, Jusseaume K, Lardner E, Wong RC, St\u00e5lhammar G et al (2023) NAD salvage pathway machinery expression in normal and glaucomatous retina and optic nerve. Acta Neuropathol Commun 11(1):18","journal-title":"Acta Neuropathol Commun"},{"issue":"7","key":"1724_CR29","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/nmeth1055","volume":"4","author":"T Misgeld","year":"2007","unstructured":"Misgeld T, Kerschensteiner M, Bareyre FM, Burgess RW, Lichtman JW (2007) Imaging axonal transport of mitochondria in vivo. Nat Methods 4(7):559\u2013561","journal-title":"Nat Methods"},{"issue":"7","key":"1724_CR30","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1083\/jcb.200706181","volume":"179","author":"GR Howell","year":"2007","unstructured":"Howell GR, Libby RT, Jakobs TC, Smith RS, Phalan FC, Barter JW et al (2007) Axons of retinal ganglion cells are insulted in the optic nerve early in DBA\/2J glaucoma. J Cell Biol 179(7):1523\u20131537","journal-title":"J Cell Biol"},{"issue":"6","key":"1724_CR31","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1007\/s00401-011-0807-1","volume":"121","author":"G Chidlow","year":"2011","unstructured":"Chidlow G, Ebneter A, Wood JPM, Casson RJ (2011) The optic nerve head is the site of axonal transport disruption, axonal cytoskeleton damage and putative axonal regeneration failure in a rat model of glaucoma. Acta Neuropathol 121(6):737\u2013751","journal-title":"Acta Neuropathol"},{"issue":"8","key":"1724_CR32","doi-asserted-by":"publisher","first-page":"e72282","DOI":"10.1371\/journal.pone.0072282","volume":"8","author":"PA Williams","year":"2013","unstructured":"Williams PA, Howell GR, Barbay JM, Braine CE, Sousa GL, John SWM et al (2013) Retinal Ganglion Cell Dendritic Atrophy in DBA\/2J Glaucoma. PLoS ONE 8(8):e72282","journal-title":"PLoS ONE"},{"issue":"3","key":"1724_CR33","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1007\/s12035-021-02675-5","volume":"59","author":"ML Risner","year":"2022","unstructured":"Risner ML, Pasini S, McGrady NR, Calkins DJ (2022) Bax contributes to retinal ganglion cell dendritic degeneration during glaucoma. Mol Neurobiol 59(3):1366\u20131380","journal-title":"Mol Neurobiol"},{"issue":"6","key":"1724_CR34","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1111\/j.1460-9568.2008.06426.x","volume":"28","author":"B Beirowski","year":"2008","unstructured":"Beirowski B, Babetto E, Coleman MP, Martin KR (2008) The WldS gene delays axonal but not somatic degeneration in a rat glaucoma model. Eur J Neurosci 28(6):1166\u20131179","journal-title":"Eur J Neurosci"},{"key":"1724_CR35","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.mito.2017.08.014","volume":"36","author":"YA Ito","year":"2017","unstructured":"Ito YA, Di Polo A (2017) Mitochondrial dynamics, transport, and quality control: a bottleneck for retinal ganglion cell viability in optic neuropathies. Mitochondrion 36:186\u2013192","journal-title":"Mitochondrion"},{"issue":"3","key":"1724_CR36","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1167\/iovs.14-16126","volume":"56","author":"L Coughlin","year":"2015","unstructured":"Coughlin L, Morrison RS, Horner PJ, Inman DM (2015) Mitochondrial morphology differences and mitophagy deficit in murine glaucomatous optic nerve. Invest Ophthalmol Vis Sci 56(3):1437\u20131446","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1724_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2019.104678","volume":"134","author":"A Loreto","year":"2020","unstructured":"Loreto A, Hill CS, Hewitt VL, Orsomando G, Angeletti C, Gilley J et al (2020) Mitochondrial impairment activates the Wallerian pathway through depletion of NMNAT2 leading to SARM1-dependent axon degeneration. Neurobiol Dis 134:104678","journal-title":"Neurobiol Dis"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-024-01724-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40478-024-01724-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-024-01724-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T16:11:53Z","timestamp":1709309513000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-024-01724-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,1]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1724"],"URL":"https:\/\/doi.org\/10.1186\/s40478-024-01724-z","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,1]]},"assertion":[{"value":"27 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All breeding and experimental procedures were performed in accordance to the Association for Research for Vision and Ophthalmology Statement for the Use of Animals in Ophthalmic and Research. Individual study protocols were approved by Stockholm\u2019s Committee for Ethical Animal Research (10389\u20132018).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"37"}}